ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table_4 #$ Diseases or disease syndromes Proportion
13 1. American Trypanosomiasis/Chagas' disease (acute) 70%
31( 17. Cyclosporiasis (healthy individuals) 98%
25 1. American Trypanosomiasis/Chagas' disease (chronic) 30%
322 17. Cyclosporiasis (immunocompromised individuals) 2%
38 2. Anaplasmosis/Canine granulocytic anaplasmosis (acute) 50%
33: 18. Cysticercosis/Taeniasis (non-neurological involvement) 99.8%
49 2. Anaplasmosis/Canine granulocytic anaplasmosis(chronic)
340 18. Cysticercosis/Taeniasis (neurocysticercosis) 0.2%
5 3. Anthrax (cutaneous) 95%
35 19. Dengue fever 99%
6 3. Anthrax (inhalational) 5%
36 19. Dengue haemorrhagic fever 1%
7 4. Babesiosis (mild)
37> 20. Eastern equine encephalitis (non-neurological involvement) 66.7%
8' 4. Babesiosis (shock and renal failure)
38G 20. Eastern equine encephalitis (encephalitic/neurological involvement) 33.3%
9- 5. Bartonellosis (Cat-scratch disease) (mild) 90%
399 21. Ebola virus haemorrhagic fever (Reston strain) 0.4%
10D 5. Bartonellosis (Cat-scratch disease) (bacteremia/systemic disease) 10%
408 21. Ebola virus haemorrhagic fever (other Ebola strains) 99.6%
11- 6. Baylisascariasis (visceral larval migrans)
41 22. Echinococcosis (cystic)
125 6. Baylisascariasis (neural or ocular larval migrans)
42 22. Echinococcosis (alveolar)
13 7. Botulism (mild)
43% 23. Escherichia coli infection 85%
14 7. Botulism (paralysis)
44A 23. Escherichia coli infection (hemolytic-uremic syndrome) 15%
15 8. Bovine Tuberculosis (latent) 92.5%
45$ 24. Giardiasis (healthy individuals)
16 8. Bovine Tuberculosis (active) 7.5%
46. 24. Giardiasis (immunocompromised individuals)
17 9. Brucellosis (mild) 75%
47, 25. Hantavirus pulmonary syndrome (moderate)
18 9. Brucellosis (undulant) 25%
487 25. Hantavirus pulmonary syndrome (respiratory failure)
19, 10. Campylobacteriosis (healthy individuals)
497 26. Hendra virus (rare, consistent prognosis suspected) 100%
206 10. Campylobacteriosis (immunocompromised individuals)
50 27. Hepatitis A (mild)
21) 11. Chlamydiosis (C. abortus spp.)
51# 27. Hepatitis A (prolonged relapse)
22' 11. Chlamydiosis (C. felis spp.)
52 28. H1N1 Influenza (mild) 97.5%
23 12. Cholera (mild) 80%
53( 28. H1N1 Influenza (respiratory failure) 2.5%
24B 12. Cholera (severe dehydration, kidney failure,hypovolemic shock) 20%
54" 29. HPAI H5N1 Influenza (moderate) 40%
25 13. Coccidioidomycosis (acute)
55- 29. HPAI H5N1 Influenza (respiratory failure) 60%
26% 13. Coccidioidomycosis (disseminated)
56 30. Japanese encephalitis (mild) 99.5%
27; 14. Crimean-Congo haemorrhagic fever (consistent prognosis)
574 30. Japanese encephalitis (neurological involvement) 0.5%
28+ 15. Cryptosporidiosis (healthy individuals)
58% 31. La Cross virus (non-encephalitic)
295 15. Cryptosporidiosis (immunocompromised individuals)
59! 31. La Cross virus (encephalitic)
30<